Because of its targeted receptor interaction, Ipamorelin is frequently examined in studies focused on hormone signaling regulation and peptide receptor interactions
doi: 10.3389/fonc.2026.1771365 Received 19 December 2025 Revised 24 February 2026 Accepted 05 March 2026 Published 31 March 2026 Volume 16 - 2026 Edited by Pritam Sadhukhan, National Institutes of Health (NIH), United States Reviewed by Ryszard Smolarczyk, Sklodowska Curie Memorial Institute, Poland Sandeep Pandey, King Georges Medical University, India Updates Copyright 2026 Sureka, Maheshwari, Agravat, Singhal, Zaman, Rishi, Siraj, Zaheer and Misra
The benefits vary by target application, and each has distinct evidence behind it
Comparative research on combined vs single-compound repair pathways